Century Therapeutics
IPSC • NASDAQ
Century Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Brent Pfeiffenberger, with a market cap of $363.0M.
CEOBrent Pfeiffenberger
Next Earnings
Upcoming earnings announcement for Century Therapeutics
Date
Thursday, May 14, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.15
Earnings History
Past 12 earnings reports for Century Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q4 2025 | -$0.25Est: -$0.29 | +13.8% | -Est: -$62.5K | +100.0% |  10-K |
| Nov 13, 2025 | Q3 2025 | -$0.40Est: -$0.35 | -14.3% | -Est: $25.0K | -100.0% | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.38Est: -$0.38 | 0.0% | - | — | 10-Q |
| May 15, 2025 | Q1 2025 | $0.89Est: -$0.31 | +387.1% | $109.2MEst: $45.5M | +139.8% | 10-Q |
| Mar 19, 2025 | Q4 2024 | -$0.43Est: -$0.44 | +2.3% | $4.2MEst: $975.0K | +328.0% | 10-K |
| Nov 5, 2024 | Q3 2024 | -$0.37Est: -$0.45 | +17.8% | $791.0KEst: $2.0M | -60.8% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.38Est: -$0.46 | +17.4% | $771.0K | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.45Est: -$0.50 | +10.0% | $855.0KEst: $1.3M | -32.1% | 10-Q |
| Mar 14, 2024 | Q4 2023 | -$0.65Est: -$0.55 | -18.2% | $268.0KEst: $1.8M | -85.4% | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.55Est: -$0.51 | -7.8% | $148.0KEst: $1.2M | -87.2% | — |
| Aug 9, 2023 | Q2 2023 | -$0.56Est: -$0.54 | -3.7% | $99.0KEst: $1.1M | -91.3% | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.53Est: -$0.52 | -1.9% | $1.7MEst: $1.3M | +31.3% | — |